Highlights

• Bliss GVS Pharma stock jumped 17.40% to ₹372.80 in Tuesday’s session.
• The stock continued its sharp upward momentum after recent sustained gains.
• RSI crossed 84.00, indicating elevated momentum and stretched conditions.

Overview

Bliss GVS Pharma Limited (NSE: BLISSGVS) remained in focus after the stock surged 17.40% to ₹372.80 on May 26, 2026. The rally pushed the stock closer to the ₹400.00 mark, with strong price expansion and rising momentum placing the counter among the top market gainers.

The company reported standalone total income of ₹22,083.91 lakh for the quarter ended March 2026. Profit before tax stood at ₹4,415.48 lakh, while net profit came at ₹3,242.25 lakh. Earnings per share (EPS) was reported at ₹3.06.

Fundamental View

Bliss GVS Pharma operates in the pharmaceutical segment with exposure to formulations and healthcare products. The latest quarterly numbers reflected profitability during the reported period, while the stock reaction suggests investors are closely monitoring earnings momentum and operational performance.

Market participants may also be tracking margin trends, export demand conditions, and developments across the broader pharma sector.

Technical View

Bliss GVS Pharma stock is trading near ₹372.80 while remaining significantly above its 21-day moving average near ₹284.73, reflecting a sharply improved near-term trend structure. Recent price action indicates sustained upward momentum, with the stock extending gains after a strong breakout phase.

The 14-day RSI climbed near 84.37, indicating overbought conditions and elevated momentum activity. Immediate support is placed around ₹340.00–₹325.00, while resistance is seen near ₹400.00–₹425.00. Sustaining above the ₹340.00 zone could help maintain upward momentum, although sharp volatility may continue at elevated levels.

Key Technical Levels

The immediate support zone is placed near ₹340.00–₹325.00, which could act as an important cushion during short-term pullbacks. On the upside, resistance is placed around ₹400.00–₹425.00. A sustained move above the ₹400.00 zone may keep bullish momentum active in the near term.

Risks to Watch

• Overbought RSI may trigger short-term profit-booking.
• Sharp volatility after rapid upward price expansion.
• Weak pharma sector sentiment could affect momentum.
• Failure to sustain above ₹340.00 may pressure trend structure.

Summary

Bliss GVS Pharma shares rallied 17.40% to ₹372.80 amid continued momentum-driven buying activity. The stock remains well above its short-term moving average, while RSI has entered overbought territory near 84.37. Traders may closely monitor whether the stock sustains above the ₹340.00 support zone and whether momentum extends toward the ₹400.00–₹425.00 resistance range.

FAQs

Why did Bliss GVS Pharma shares rise sharply today?

The stock surged amid strong momentum activity and continued upward price expansion in recent sessions.

What does the RSI indicate for Bliss GVS Pharma stock?

The RSI near 84.37 indicates elevated momentum and overbought trading conditions.

What are the key levels to watch in Bliss GVS Pharma shares?

Support is placed near ₹340.00–₹325.00, while resistance is seen around ₹400.00–₹425.00.